[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT3524609T - Método para a preparação de derivados de 3-fenil- 2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros óticos dos mesmos, e intermediários do processo - Google Patents

Método para a preparação de derivados de 3-fenil- 2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros óticos dos mesmos, e intermediários do processo

Info

Publication number
PT3524609T
PT3524609T PT178586665T PT17858666T PT3524609T PT 3524609 T PT3524609 T PT 3524609T PT 178586665 T PT178586665 T PT 178586665T PT 17858666 T PT17858666 T PT 17858666T PT 3524609 T PT3524609 T PT 3524609T
Authority
PT
Portugal
Prior art keywords
hexahydropyrano
phenyl
optical isomer
synthesizing optical
chromene derivative
Prior art date
Application number
PT178586665T
Other languages
English (en)
Original Assignee
Glaceum Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum Inc filed Critical Glaceum Inc
Publication of PT3524609T publication Critical patent/PT3524609T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
PT178586665T 2016-10-04 2017-09-27 Método para a preparação de derivados de 3-fenil- 2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros óticos dos mesmos, e intermediários do processo PT3524609T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20160127805 2016-10-04

Publications (1)

Publication Number Publication Date
PT3524609T true PT3524609T (pt) 2021-07-15

Family

ID=61831886

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178586665T PT3524609T (pt) 2016-10-04 2017-09-27 Método para a preparação de derivados de 3-fenil- 2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros óticos dos mesmos, e intermediários do processo

Country Status (19)

Country Link
US (2) US10669282B2 (pt)
EP (1) EP3524609B1 (pt)
JP (1) JP6810275B2 (pt)
KR (2) KR20180037584A (pt)
CN (1) CN109863152B (pt)
AR (1) AR109735A1 (pt)
AU (1) AU2017338514B2 (pt)
BR (1) BR112019006736A8 (pt)
CA (1) CA3039326C (pt)
DK (1) DK3524609T3 (pt)
ES (1) ES2881000T3 (pt)
HU (1) HUE055701T2 (pt)
IL (1) IL265706B (pt)
MX (1) MX2019003818A (pt)
PL (1) PL3524609T3 (pt)
PT (1) PT3524609T (pt)
TW (1) TWI641610B (pt)
WO (1) WO2018066872A1 (pt)
ZA (1) ZA201902760B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2964146T3 (es) 2016-06-29 2024-04-04 Glaceum Inc Derivado de piranocromenilfenol ópticamente activo y composición farmacéutica que lo comprende
KR20180037584A (ko) * 2016-10-04 2018-04-12 주식회사 글라세움 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법
TWI804600B (zh) * 2018-04-03 2023-06-11 南韓商格雷森伍股份有限公司 3-苯基-2,8-二氫吡喃[2,3-ƒ]苯并哌喃衍生物的合成方法
KR20200038182A (ko) 2018-10-02 2020-04-10 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
WO2020071818A1 (ko) * 2018-10-02 2020-04-09 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
KR20200105198A (ko) * 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
KR102692932B1 (ko) 2019-07-30 2024-08-07 주식회사 글라세움 2-((6-(히드록시메틸)크로멘-5-일)옥시)-1-페닐에타논 유도체의 합성 방법
KR20240078928A (ko) * 2022-11-28 2024-06-04 가톨릭대학교 산학협력단 침샘 오가노이드 안정화 및 침샘조직 재생 유도 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100565423B1 (ko) * 2003-10-20 2006-03-30 빅 바이오 주식회사 이소플라반 유도체 또는 이소플라벤 유도체의 제조방법
JP2006008604A (ja) * 2004-06-25 2006-01-12 Kuraray Co Ltd イソフラバン誘導体の製造方法
WO2007058480A1 (en) * 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
US8563599B2 (en) * 2008-03-03 2013-10-22 The United States Of America, Represented By The Secretary Of Agriculture Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof
CN101555259B (zh) * 2009-05-15 2012-06-27 中国科学院上海有机化学研究所 螺环骨架膦噁唑啉配体、合成方法及其在不对称氢化反应中的应用
CN103030647B (zh) * 2013-01-16 2014-10-29 山东省分析测试中心 一种光甘草定的合成方法
KR102344479B1 (ko) 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
ES2964146T3 (es) 2016-06-29 2024-04-04 Glaceum Inc Derivado de piranocromenilfenol ópticamente activo y composición farmacéutica que lo comprende
KR20180037584A (ko) * 2016-10-04 2018-04-12 주식회사 글라세움 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법

Also Published As

Publication number Publication date
KR20180037584A (ko) 2018-04-12
PL3524609T3 (pl) 2021-12-27
ZA201902760B (en) 2021-09-29
MX2019003818A (es) 2019-08-12
WO2018066872A1 (ko) 2018-04-12
JP6810275B2 (ja) 2021-01-06
HUE055701T2 (hu) 2021-12-28
US20200048272A1 (en) 2020-02-13
US10669282B2 (en) 2020-06-02
IL265706A (en) 2019-05-30
EP3524609A4 (en) 2020-04-08
ES2881000T3 (es) 2021-11-26
TWI641610B (zh) 2018-11-21
JP2019529577A (ja) 2019-10-17
AU2017338514B2 (en) 2020-05-14
AU2017338514A1 (en) 2019-05-23
KR20180091803A (ko) 2018-08-16
US20200199142A1 (en) 2020-06-25
CN109863152A (zh) 2019-06-07
TW201813970A (zh) 2018-04-16
KR101893393B1 (ko) 2018-08-30
CA3039326A1 (en) 2018-04-12
NZ753171A (en) 2021-05-28
IL265706B (en) 2021-06-30
EP3524609A1 (en) 2019-08-14
AR109735A1 (es) 2019-01-16
CA3039326C (en) 2022-09-20
BR112019006736A2 (pt) 2019-07-23
DK3524609T3 (da) 2021-07-26
US10947250B2 (en) 2021-03-16
CN109863152B (zh) 2021-12-03
EP3524609B1 (en) 2021-05-26
BR112019006736A8 (pt) 2022-08-23

Similar Documents

Publication Publication Date Title
ZA201902760B (en) Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and optical isomer of thereof
EP3537432A4 (en) LANGUAGE SYNTHESIS PROCEDURE
EP3398957A4 (en) PROCESS FOR SYNTHESIS OF ETELCALCETIDE
EP3342874A4 (en) PROCESS FOR PRODUCING AROMATIC COMPOUND AND DERIVATIVE THEREOF
PL3453766T3 (pl) Sposób wytwarzania związków inkluzyjnych flawonoidów
ZA201906079B (en) Novel ester compounds, method for the production thereof and use thereof
EP3642181A4 (en) 4-METHOXYPYRROLE DERIVATIVE INTERMEDIATE PREPARATION PROCESS
ZA201905065B (en) Novel ester compounds, method for the production thereof and use thereof
EP3309138A4 (en) Method for co-production of 2,3,3,3-tetrafluoropropylene and 1,3,3,3-tetrafluoropropylene
EP3708567A4 (en) PROCESS FOR THE PREPARATION OF A BENZOFURANE DERIVATIVE
EP3434262A4 (en) PROCESS FOR PREPARING MICROGRANULATE WITH DELAYED RELEASE
EP3327505A4 (en) NEW COMPOUND AND METHOD FOR PRODUCING THE SAME
EP3630722A4 (en) 4-METHOXYPYRROLE DERIVATIVE INTERMEDIATE PREPARATION PROCESS
ZA201906848B (en) Novel pyrrolopyridine derivative, method for producing same, and use thereof
EP3590912A4 (en) PROCESS FOR PRODUCING PERFLUORALCADIUM COMPOUNDS
EP3549711A4 (en) CORE ADJUSTMENT PROCEDURE
EP3486236A4 (en) SYNTHESIS PROCESS AND INTERMEDIATE PRODUCT FOR PROTHIOCONAZOLE AND ENANTIOMES THEREOF
EP3351534A4 (en) PROCESS FOR PREPARING A NOVEL 4-BENZAZONINE DERIVATIVE
EP3266775A4 (en) Method for producing 1,2,4-oxadiazole derivative
EP3176164A4 (en) Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
EP3712157A4 (en) PYRIDOPYRIMIDINE COMPOUNDS ACTING AS DOUBLE KINASE MTORC 1/2 INHIBITORS
EP3521272A4 (en) STILEN DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF
EP3447060A4 (en) NOVEL ORGANOSILICATED COMPOUND AND METHOD FOR ITS PRODUCTION
EP3424903A4 (en) PROCESS FOR PRODUCING SULFOXIDE DERIVATIVE
PL3782999T3 (pl) Sposób syntetyzowania pochodnej 3-fenylo-2,8-dihydropirano[2,3- f]chromenu